Back to search

A hepatitis B vaccine formulated with a novel adjuvant system

Data up to Jan 2025

Published2000
Citations62
References36
Clinical Trials (1)

Total Citations Per Year

Abstract

References (36)

Viral Hepatitis and Liver Disease

1985 • 1,886 citations

Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual Men

1986 • 628 citations

Adjuvants for human vaccines—current status, problems and future prospects

1995 • 546 citations

A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report

1981 • 451 citations

Viral Hepatitis and Liver Disease

1988 • 445 citations

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

1996 • 376 citations

Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan

1996 • 296 citations

Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long‐term antibody persistence

1994 • 163 citations

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

1998 • 158 citations

Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations

1989 • 156 citations

Protective Efficacy of a Recombinant DNA Hepatitis B Vaccine in Neonates of HBe Antigen—Positive Mothers

1989 • 148 citations

Global Control of Hepatitis B Through Vaccination: Role of Hepatitis B Vaccine in the Expanded Programme on Immunization

1989 • 139 citations

Response to hepatitis B vaccine: multiple HLA genes are involved

1998 • 137 citations

Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers

1992 • 125 citations

Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness

1988 • 80 citations

Inactivated hepatitis A vaccine: long-term antibody persistence

1997 • 60 citations

Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines

1994 • 58 citations

Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects.

1987 • 51 citations

A prospective study of in vitro anti‐HBs producing B cells (spot‐ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls

1991 • 48 citations

Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedules

1990 • 44 citations

The adjuvant properties of a nontoxic monophosphoryl lipid A in hyporesponsive and aging mice.

1987 • 42 citations

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences 2. Immunogenicity in poor responders to hepatitis B vaccines

1997 • 41 citations

The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen.

1989 • 35 citations

Hepatitis B vaccine boosting: the debate continues

1995 • 34 citations

Pharmacologic basis for the use of doxazosin in the treatment of essential hypertension

1989 • 31 citations

Hepatitis B Vaccine: Current Issues

1997 • 30 citations

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults

1997 • 30 citations

Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine

1998 • 29 citations

Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers

1989 • 27 citations

Persistenz von Antikörpern gegen Hepatitis-B-Oberflächenantigen nach Impfung gegen Hepatitis B

2008 • 22 citations

Hepatitis in travellers: epidemiology and prevention

1993 • 20 citations

[Hepatitis B immunization--when is a booster injection necessary?].

1985 • 20 citations

Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients

1989 • 18 citations

Persistence of antibodies following vaccination with a yeast-derived recombinant hepatitis B vaccine

1988 • 16 citations

Immunologic Prevention of Human Hepatitis

1984 • 8 citations

Immunisation of homosexual men with a recombinant DNA vaccine against hepatitis B: immunogenicity and protection

1988 • 7 citations

Cited By (0)

Loading...
A hepatitis B vaccine formulated with a novel adjuvant system (2000) – Vaccine | Metascience Observatory Explorer